The board of Austar Lifesciences Limited will convene on 25 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes consideration of an interim dividend declaration.
The meeting date was disclosed in an announcement released on 13 August 2026. As of that date, Austar’s Board consists of four executive directors (Ho Kwok Keung Mars, Ho Kin Hung, Zhou Ning and Bian Ce), one non-executive director (Ji Lingling) and three independent non-executive directors (Cheung Lap Kei, Chiu Hoi Shan and Leung Oi Kin).
Chairman and Chief Executive Officer Ho Kwok Keung Mars signed the notice on behalf of the Board.
Comments